M Yokota

Improvement of Cisplatin Toxicity and Lethality by Juzen-taiho-to in Mice.

Kiyoshi Sugiyama, Harumi Ueda, Yoshimasa Ichio et al. · Biological and Pharmaceutical Bulletin · 1995 · 33 citations · Full text

In Vitro Pharmacologic Profile of YM158, a New Dual Antagonist for LTD4 and TXA2 receptors

Yasuhito Arakida, M Yokota, Toshimitsu Yamada et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 29 citations

4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline Derivatives. II. Their Renal Vasodilation Activity and Structure-Activity Relationship.

Akihiro Tanaka, Ryuji Tsuzuki, M Yokota et al. · Chemical and Pharmaceutical Bulletin · 1996 · 15 citations · Full text

Medicinal Chemistry, Derivative (Chemistry), Biochemistry +13

The clinical evaluation of novel polymethyl methacrylate membrane with a modified membrane surface: a multicenter pilot study

Nobuko Uchiumi, Koji Sakuma, Sumihiko Sato et al. · Renal Replacement Therapy · 2018 · 15 citations · Full text

Engineering, Dialysis, Membrane Characterization +24

Synthesis, Resolution, and Renal Vasodilation Activity of Novel DA1 Agonists: 4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline Derivatives.

Akihiro Tanaka, Ryuji Tsuzuki, M Yokota et al. · Chemical and Pharmaceutical Bulletin · 1991 · 10 citations · Full text

Hypertension, Heart Failure, Pharmaceutical Science +23